VEDANTA PARTNERS, LLC purchased 1.33M shares of REVIVA PHARMACEUTICALS HOLDINGS, INC. on the open market
Open‑market purchase worth $4.99M. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/3/2021ACC: 0001062993-21-005353
10% Owner
Since Jun 2021
+2.66M
Net shares
Net buyer
$4.99M
Total acquired
2
Open market trades
2B · 0S
4
Total transactions
2.66M acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+931K
Price / share
$3.75
Trade value
$3.49M
% of position
New position
6/1/2021
0.00→931K
Common Stock
Indirect
Shares
+399K
Price / share
$3.75
Trade value
$1.50M
% of position
New position
6/1/2021
0.00→399K
Total
Net shares
+1.33M
Net value
$4.99M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/1/2021 | P · Purchase | +931K | $3.75 | $3.49M | New position | 0.00 | 931K |
| Common Stock Indirect | 6/1/2021 | P · Purchase | +399K | $3.75 | $1.50M | New position | 0.00 | 399K |
| Total | +1.33M | $4.99M | ||||||
Derivative Transactions2
Warrants (right to buy)
Indirect
Converts to
Common Stock
698.25K shares
Shares
+931K
Strike price
4.125
Held after
931K
Exercisable
—
6/1/2021
Warrants (right to buy)
Indirect
Converts to
Common Stock
299.25K shares
Shares
+399K
Strike price
4.125
Held after
399K
Exercisable
—
6/1/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (right to buy) Indirect | Common Stock698.25K shares | 6/1/2021 | P · Purchase | +931K | 4.125 | — | 931K |
| Warrants (right to buy) Indirect | Common Stock299.25K shares | 6/1/2021 | P · Purchase | +399K | 4.125 | — | 399K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned99.54K
Common Stock
IndirectShares owned871.34K
Total
970.88K indirect970.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 99.54K | Indirect |
| Common Stock | 871.34K | Indirect |
| Total | 970.88K | 970.88K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported